ctrl K

Watchlist Price Alert

Bellevue Life Sciences Ac... (BLAC)

NASDAQ: BLAC · Real-Time Price · USD

3.01

-3.72 (-55.27%)

At close: Feb 14, 2025, 3:53 PM

Bellevue Life Sciences Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15.42K	124.5K	4.76K	62.65K
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	36.61M	n/a	n/a	n/a
Other Long-Term Assets	n/a	1.1M	700.33K	260.1K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	22.63K	124.5K	4.76K	62.65K
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	36.61M	1.1M	700.33K	260.1K
Total Assets	36.63M	1.23M	705.09K	322.75K
Account Payables	n/a	34K	2.85K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	1.2M	400K	300K
Other Current Liabilities	1.51M	n/a	n/a	n/a
Total Current Liabilities	2.04M	1.26M	707.21K	321.56K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.07M	n/a	n/a	n/a
Total Long-Term Liabilities	2.07M	1.23M	n/a	n/a
Total Liabilities	4.11M	1.26M	707.21K	321.56K
Total Debt	n/a	1.2M	400K	300K
Common Stock	36.43M	173.00	173.00	173.00
Retained Earnings	-3.91M	-62.51K	-27.12K	-23.81K
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	32.52M	-37.51K	-2.12K	1.19K
Total Investments	36.61M	n/a	n/a	n/a